Yungjin and Servier on a business alliance.

Yungjin and Servier have agreed jointly to market Acertil, an ACE inhibitor anti-hypertension drug, and Diamicron MR, an anti-diabetic drug in Korea starting from Oct. this year after celebrating their business association at Daemyeong condo in Danyang on Oct. 7.

The yearly sales of Diamicron and Acertil in Korea showed respectively at the level of 10 BW and 4 BW, which will be lifted up by ...